Search by Drug Name or NDC
NDC 00143-9745-05 Granisetron Hydrochloride 1 mg/mL Details
Granisetron Hydrochloride 1 mg/mL
Granisetron Hydrochloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is GRANISETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Granisetron immediate-release injection is used to prevent nausea and vomiting caused by cancer chemotherapy and to prevent and treat nausea and vomiting that may occur after surgery. Granisetron extended-release (long-acting) injection is used with other medications to prevent nausea and vomiting caused by cancer chemotherapy that may occur immediately or several days after receiving chemotherapy medications. Granisetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
Related Packages: 00143-9745-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Granisetron Injection
Product Information
| NDC | 00143-9745 |
|---|---|
| Product ID | 0143-9745_3b366664-32e3-4d5c-b75c-0b764ffa31f6 |
| Associated GPIs | 50250035102015 |
| GCN Sequence Number | 021693 |
| GCN Sequence Number Description | granisetron HCl VIAL 1 MG/ML INTRAVEN |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 60548 |
| HICL Sequence Number | 007611 |
| HICL Sequence Number Description | GRANISETRON HCL |
| Brand/Generic | Generic |
| Proprietary Name | Granisetron Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Granisetron Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | GRANISETRON HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078629 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00143-9745-05 (00143974505)
| NDC Package Code | 0143-9745-05 |
|---|---|
| Billing NDC | 00143974505 |
| Package | 5 VIAL, MULTI-DOSE in 1 CARTON (0143-9745-05) / 4 mL in 1 VIAL, MULTI-DOSE (0143-9745-01) |
| Marketing Start Date | 2009-12-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |